TrialBritish journal of cancer2005

Two randomised phase II trials of subcutaneous interleukin-2 and histamine dihydrochloride in patients with metastatic renal cell carcinoma.

F Donskov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.